Eric Hedrick
Net worth: 1 M $ as of 2023-10-30
Career history of Eric Hedrick
Former positions of Eric Hedrick
| Companies | Position | Start | End |
|---|---|---|---|
| EQRX, INC. | Corporate Officer/Principal | 2020-07-31 | 2023-11-08 |
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 2015-05-31 | 2016-08-23 |
| EPIZYME, INC. | Chief Tech/Sci/R&D Officer | 2012-05-16 | 2014-10-30 |
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 2011-07-26 | - |
| Corporate Officer/Principal | 2010-10-28 | 2012-04-12 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2009-08-31 | 2009-08-31 |
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 2019-01-22 | - |
Training of Eric Hedrick
| University of Maryland | Doctorate Degree |
| Boston University | Undergraduate Degree |
Statistics
International
| United States | 7 |
| Cayman Islands | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| EQRX, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Eric Hedrick
- Experience
